HIV/AIDS Clinical Trials

Find HIV/AIDS Clinical Trials Near You

A Feasibility Study of Working Memory Training for People Aging with HIV

Status: Recruiting
Location: See location...
Intervention Type: Behavioral
Study Type: Interventional
Study Phase: Early Phase 1
SUMMARY

The present study investigates the feasibility of working memory training in people aging with HIV (PAWHIV). In a cross-over design this stage 1 feasibility trial, will evaluate acceptability, and estimate possible effect sizes related to working memory training by examining potential differential effects in PAWHIV and those aging without HIV. This project highlights the importance of tailored cognitive assessments and interventions, engaging with underrepresented communities to enhance inclusivity in cognitive health research.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 50
Maximum Age: 85
Healthy Volunteers: t
View:

• 50-85 years of age

• Able to understand and speak English and follow study procedures

• Does not have a psychological or neurological condition that would prevent being able to give consent to participate

• Not currently involved in any other cognitive or memory training studies

Locations
United States
Massachusetts
Northeastern University
RECRUITING
Boston
Contact Information
Primary
Morgan Gomez
gomez.mo@northeastern.edu
‪(774) 226-9323‬
Backup
Audrey Carrillo, MA
a.carrillo@northeastern.edu
Time Frame
Start Date: 2024-07-15
Estimated Completion Date: 2025-12-31
Participants
Target number of participants: 80
Treatments
Active_comparator: Non-gamified First
Training type 1 will be administered in the first part of the crossover trial and Training type 2 will be administered in the second part of the trial. Each training part consists of 20 twenty-minute long sessions with the recommended frequency of 2 sessions per work day. Thus each training part can be completed in 10 work days (2 weeks).
Active_comparator: Gamified First
Training type 2 will be administered in the first part of the crossover trial and Training type 1 will be administered in the second part of the trial. Each training part consists of 20 twenty-minute long sessions with the recommended frequency of 2 sessions per work day. Thus each training part can be completed in 10 work days (2 weeks).
Related Therapeutic Areas
Sponsors
Leads: Northeastern University

This content was sourced from clinicaltrials.gov